Does UMBRALISIB Cause Off label use? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Off label use have been filed in association with UMBRALISIB. This represents 4.4% of all adverse event reports for UMBRALISIB.
13
Reports of Off label use with UMBRALISIB
4.4%
of all UMBRALISIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Off label use From UMBRALISIB?
Of the 13 reports, 1 (7.7%) resulted in death.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMBRALISIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does UMBRALISIB Cause?
Diarrhoea (47)
Nausea (36)
Disease progression (30)
Fatigue (30)
Covid-19 (16)
Nervous system disorder (15)
Death (14)
Asthenia (13)
Product dose omission issue (12)
Anaemia (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which UMBRALISIB Alternatives Have Lower Off label use Risk?
UMBRALISIB vs UMECLIDINIUM
UMBRALISIB vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMBRALISIB vs UMIFENOVIR
UMBRALISIB vs UNSPECIFIED INGREDIENT
UMBRALISIB vs UPADACITINIB